Provided by Tiger Trade Technology Pte. Ltd.

Penumbra

339.30
+0.58000.17%
Post-market: 340.501.20+0.35%16:10 EST
Volume:551.72K
Turnover:187.56M
Market Cap:13.29B
PE:81.99
High:341.66
Open:338.84
Low:338.84
Close:338.72
52wk High:362.41
52wk Low:221.26
Shares:39.16M
Float Shares:37.83M
Volume Ratio:0.70
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.14
EPS(LYR):0.3600
ROE:13.32%
ROA:6.70%
PB:9.78
PE(LYR):942.50

Loading ...

Penumbra’s Indigo Post‑Market Study in Japan Reaches Completion, Setting the Stage for New Real‑World Data

TIPRANKS
·
Feb 05

Boston Scientific Corp Outlook Q1 2026 Adjusted EPS of $0.78 to $0.80

THOMSON REUTERS
·
Feb 04

Boston Scientific Corp: Net Sales Growth for Q1 of 2026 to Be Approx 10.5 to 12.0 Percent on a Reported Basis

THOMSON REUTERS
·
Feb 04

Is Peninsula Energy (ASX:PEN) Quietly Reframing Its Uranium Ambitions Through Mine Unit 4’s Outperformance?

Simply Wall St.
·
Jan 31

BTIG Remains a Hold on Penumbra (PEN)

TIPRANKS
·
Jan 27

Boston Scientific Builds Neurovascular Scale With US$14.5b Penumbra Deal

Simply Wall St.
·
Jan 27

Peninsula Energy (ASX:PEN) Valuation Check As Lance Reset Progresses Ahead Of Schedule

Simply Wall St.
·
Jan 26

Assessing Penumbra (PEN) Valuation After Strong Recent Share Price Momentum

Simply Wall St.
·
Jan 25

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

Dow Jones
·
Jan 24

Is Peninsula Energy’s (ASX:PEN) Lance Acidification Reset Quietly Redefining Its Long-Term Uranium Strategy?

Simply Wall St.
·
Jan 23

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface

Benzinga_recent_news
·
Jan 22

RBC Downgrades Penumbra to Sector Perform From Outperform, Raises Price Target to $374 From $355

MT Newswires Live
·
Jan 20

Penumbra Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
Jan 20

Penumbra downgraded to Sector Perform from Outperform at RBC Capital

TIPRANKS
·
Jan 20

Penumbra downgraded to Hold from Buy at Canaccord

TIPRANKS
·
Jan 20

Penumbra: Rating Cut to Hold as Boston Scientific Takeout Caps Upside at $374 Deal Price

TIPRANKS
·
Jan 20

Boston Scientific: Undervalued Ahead of Strong Q4 Results, 2026 Outlook, and PEN Acquisition Catalyst

TIPRANKS
·
Jan 17

BUZZ-Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout

Reuters
·
Jan 17

Penumbra Inc : Needham Cuts to Hold From Buy

THOMSON REUTERS
·
Jan 16

BTIG Downgrades Penumbra to Neutral From Buy

MT Newswires Live
·
Jan 16